Merit Medical Systems Inc/ US5898891040 /
2024-06-04 10:00:00 PM | Chg. +0.6100 | Volume | Bid10:00:10 PM | Ask10:00:10 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
82.7900USD | +0.74% | 207,622 Turnover: 10.21 mill. |
59.0000Bid Size: 100 | 84.0500Ask Size: 300 | 4.81 bill.USD | - | 50.48 |
Assets
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 292.8200 | 331.4520 | 378.7850 | 382.7280 | 371.6580 | ||||||
Intangible Assets | - | - | - | - | - | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 795.6900 | 1,190.1780 | 1,302.7830 | 1,234.6890 | 1,166.0820 | ||||||
Inventories | 155.2880 | 197.5360 | 225.6980 | 198.0190 | 221.9220 | ||||||
Accounts Receivable | 105.5360 | 137.1740 | 155.3650 | 146.6410 | 152.3010 | ||||||
Cash and Cash Equivalents | 32.3360 | 67.3590 | 44.3200 | 56.9160 | 67.7500 | ||||||
Current Assets | 316.1210 | 429.8340 | 454.5380 | 429.7070 | 482.2120 | ||||||
Total Assets | 1,111.8110 | 1,620.0120 | 1,757.3210 | 1,664.3960 | 1,648.2940 |
Liabilities
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 34.9310 | 54.0240 | 54.6230 | 49.8370 | 55.6240 | ||||||
Long-term debt | 259.0130 | 373.1520 | 431.9840 | 343.7220 | 234.3970 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 25.6000 | 59.5000 | 48 | - | - | ||||||
Liabilities | 435.4770 | 687.2370 | 807.3770 | 705.8210 | 608.4950 | ||||||
Share Capital | 353.3920 | 571.3830 | 587.0170 | 606.2240 | 641.5330 | ||||||
Total Equity | 676.3340 | 932.7750 | 949.9440 | 958.5750 | 1,039.7990 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 1,111.8110 | 1,620.0120 | 1,757.3210 | 1,664.3960 | 1,648.2940 |
Income Statement
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 727.8520 | 882.7530 | 994.8520 | 963.8750 | 1,074.7510 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 33.0690 | 58.6170 | 15.4340 | -1.5620 | 60.9160 | ||||||
Interest Income | -7.3550 | -9.1610 | -12.4130 | -9.9940 | -5.2610 | ||||||
Income Before Taxes | 35.8810 | 49.5190 | 2.1930 | -13.2310 | 53.9170 | ||||||
Income Taxes | 8.3580 | 7.5020 | -3.2580 | -3.3880 | 5.4630 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 27.5230 | 42.0170 | 5.4510 | -9.8430 | 48.4540 |
Per Share
Cash Flow
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 62.7270 | 86.5330 | 77.8130 | 165.2700 | 147.2310 | ||||||
Cash Flow from Investing Activities | -146.7610 | -378.8200 | -134.4810 | -58.6520 | -37.1610 | ||||||
Cash Flow from Financing | 96.5170 | 328.2800 | 33.5330 | -95.7060 | -98.4350 | ||||||
Decrease / Increase in Cash | 13.1650 | 35.0230 | -23.0390 | 12.5960 | 10.8340 | ||||||
Employees | 4,876 | 5,783 | 6,355 | - | - |